Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of APOE polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | IHC-P,WB-Tr |
More info about APOE polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB2987 |
| Product name: | APOE polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of APOE. |
| Gene id: | 348 |
| Gene name: | APOE |
| Gene alias: | AD2|LPG|MGC1571|apoprotein |
| Gene description: | apolipoprotein E |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human APOE. |
| Protein accession: | NP_000032;P02649 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) Immunohistochemistry (1:10-50) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of APOE (arrow) using rabbit APOE polyclonal antibody (Cat # PAB2987). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the APOE gene (Lane 2) (Origene Technologies). |
| Applications: | IHC-P,WB-Tr |
| Shipping condition: | Dry Ice |
| Publications: | The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample.Christensen H, Batterham PJ, Mackinnon AJ, Jorm AF, Mack HA, Mather KA, Anstey KJ, Sachdev PS, Easteal S. BMC Geriatr. 2008 Jul 14;8:14. |